Sentiment in Nvidia Turns Negative, Down to 41/100 At Market Open (NVDA)

No other company has been as important as NVIDIA (NASDAQ: NVDA) in 2025, but today retail investors are souring on earth’s ...

Chiesi Global Rare Diseases and Protalix BioTherapeutics Seek Re-examination from the EMA for the Negative Opinion for Elfabrio (pegunigalsidase alfa) Alternative Dos…

Every two weeks remains approved as a dosing regimen of Elfabrio in the EU --PARMA, Italy and CARMIEL, Israel, Nov. 03, 2025 ...